Intestinal barrier function is impaired in patients with PD placing them at higher risk to be exposed to microbial products [91], therefore the translocation of bacteria or bacterial-derived products such as LPS (a TLR4 ligand) can induce a systemic inflammation, producing a more severe neurodegeneration. Here, TLR4 is linked to Parkinson disease.